We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 13,693

FDA issues draft guidance on use of patient preference information in certain medical device pre-market submissions and labeling
  • Barnes & Thornburg LLP
  • USA
  • May 27 2015

The Food and Drug Administration (FDA) recently issued a draft guidance titled, "Patient Preference Information - Submission, Review in PMAs, HDE


NYAG, GNC sign landmark herbal supplement agreement
  • Klein Moynihan Turco LLP
  • USA
  • March 31 2015

This Monday, New York Attorney General Eric T. Schneiderman called off an investigation involving herbal supplements manufactured, marketed and sold


Assembly of a product amounts to manufacturing for the purposes of the liability for Defective Products Act 1991
  • A&L Goodbody
  • USA
  • July 21 2015

In McGarry v McGarry & ors 2015 IEHC 426 the High Court made a finding of liability for personal injuries against the third defendant who was the


Former senior executives indicted for illegal marketing of a medical device
  • Arnall Golden Gregory LLP
  • USA
  • May 27 2015

Two former senior executives were indicted with violations of the Food, Drug, and Cosmetic Act relating to the introduction of adulterated or


Is organic the new natural?: the impact of a court holding that an “organic” claim is not preempted by federal law
  • Venable LLP
  • USA
  • May 28 2015

By now, class action suits over foods using the term "natural" are old news following the age old American story: class action plaintiff meets


Lumber Liquidators faces civil and criminal lawsuits due to allegations of excessive formaldehyde in its flooring products
  • Alston & Bird LLP
  • USA
  • May 20 2015

On May 28, the Judicial Panel on Multidistrict Litigation will hear oral arguments about whether to consolidate and centralize class action lawsuits


Break on through to the other side: an update on Breakthrough Therapy designation requests
  • Arnall Golden Gregory LLP
  • USA
  • May 27 2015

A recent public meeting on Breakthrough Therapy (BT) Designation after 2 years from implementation provided some interesting insight and trend


FDA launches medical device database: accessGUDID
  • Thompson Coburn LLP
  • USA
  • May 26 2015

On May 4, 2015, the FDA launched the most recent component of its "Unique Device Identification System," or "UDI System," first created in September


The FTC focusing efforts against misleading dietary supplements advertising
  • Herzog Fox & Neeman
  • USA
  • May 26 2015

Recently, the Federal Trade Commission ("FTC") has been focusing on enforcement against misleading advertising and practice in the dietary supplements


WHO rejects U.S.’s appeal regarding its COOL measures
  • Alston & Bird LLP
  • Canada, Mexico, USA
  • May 27 2015

On Monday, May 18, 2015, the World Trade Organization issued a compliance panel report in the case regarding the U.S.'s country of origin labeling